The Food and Drug Administration (FDA) is considering revoking its authorization of Pfizer’s COVID-19 jab for healthy children under the age of 5, CNBC reports.
Pfizer’s experimental injection has been available for infants and young children under emergency use authorization (EUA) since June 2022, but it has never gained full approval.
“If
Continue reading

Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!